5.100
−15,00%
2026-10-09
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -13.5% | -14.4% | 0 / 3 | -11.6% | -1.73 pp | -0.53 pp | +4.7% | 0.35 | 9.98 | 10,0 | −11,6% | 2,5 | −13,5% | 9.98 | 14.95 | −33,2% |
| Pts | 0 | 0 | 0 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.100 (close price on 2026-10-09)EPS (TTM): 511,0
Financial charts
1.Revenue & growth
VND bn10,0Q3/26
1.Revenue & growth
VND bn10,0Q3/26
2.Profit & growth
VND bn2,52Q3/26
3.Profit mix (Penman)
VND bn6,32Q3/26
4.Margins & cost structure
%35.8%Q3/26
5.Returns & cash cycle
% · days5.7%Q3/26
6.Earnings quality & cash
VND bn14,2Q3/26
7.Asset structure
VND bn202Q3/26
8.Funding & debt health
VND bn · times202Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %10,0×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %210Q3/26
Adjusted EPS growth, latest quarter
-13.5%
Average adjusted EPS growth, 3 quarters
-15.0%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26